OXIS International Inc is a company which is engaged in the research, development and sale of products relating to potent antioxidant. This company manufactures products that counteract the side effects of ‘oxidative stress’.
The company has many therapeutic compounds that include anti-inflammatory and therapeutic antioxidant medicines that help in the treatment of Alzheimer’s and Parkinson’s disease, cardiovascular diseases and diabetic problems. The main focus of the company is on naturally occurring protective substances as they are likely to be more safer.
The company’s primary product includes L-Ergothioneine (ERGO) and has several patents related to ERGO. Ergothioneine is the one which conserves and maintains the levels of other antioxidants like Vitamin E, Vitamin C and Glutathione. It also reduces the side effects of environmental ultra violet radiation. Ergothioneine is a powerful antioxidant and remains the only significant source of pure I-ergothioneine worldwide.
OXIS also focuses on Therapeutic compounds and clinical products. Therapeutic compounds and clinical products are used in treating various diseases. The company is developing and is planning to sell Nutraceutical as well as Cosmecuetical products that include natural ingredients beneficial to human health.
The company’s main focus is on consumer’s health concerns that include aging and age-related disorders like Brain Health, Anti-Aging, Skin Health and Blood Sugar Regulation.
OXIS is planning to launch Ergo-Pur and Ergo-Plex shortly.
http://www.oxis.com
Oxis on Twitter
Oxis on facebook

http://www.oxis.com
Oxis on Twitter
Oxis on facebook

No comments:
Post a Comment